FDA Approves Tonix's Innovative Fibromyalgia and Chronic Pain Treatment
TL;DR Summary
Tonix Pharmaceuticals' drug Tonmya has received FDA approval for treating fibromyalgia in adults, marking the first new therapy in over 15 years for this condition. The medication, a non-opioid, once-daily sublingual tablet, demonstrated significant pain reduction in clinical trials and is expected to be available in the US by late 2025.
- Tonix Pharma's Drug Gets FDA Nod For Chronic Pain Condition, First New Therapy In Over 15 Years Yahoo Finance
- FDA approves Tonix’s Tonmya to treat fibromyalgia Yahoo Finance
- Tonix Wins Approval For First New Fibromyalgia Drug in Over 15 Years BioSpace
- US FDA approves Tonix Pharma's drug to manage pain related to chronic condition Reuters
- FDA approves landmark fibromyalgia drug that works like no other New Atlas
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 2 min read
Condensed
87%
379 → 51 words
Want the full story? Read the original article
Read on Yahoo Finance